PTPRN and diabetes mellitus: Several studies have shown that SPK recipients can develop or retain antibodies against islet antigens such as GAD65, IA-2, and ZnT8, which may signal the early recurrence of diabetes or contribute to pancreas graft dysfunction [58,67].